Evonik Industries, one of the world leaders in specialty chemicals, will implement price increases for its pharmaceutical excipients and medical device polymers sold under the Eudragit and Resomer brands. Depending on the product grade, the sales price increase will be up to 12 per cent and become effective for shipments after November 1, 2014.
This price adjustment is necessary to maintain the high level of service and quality Evonik customers are accustomed to. Evonik is committed to investments that enhance the quality and availability of supplies and services which support its customers’ growth. The continuous expansion of the global lab and manufacturing resources exemplifies this commitment.
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. The company is active in over 100 countries around the world.